Cargando…

Medication-related osteonecrosis of the jaw (MRONJ) and eNOS Polymorphisms in multiple myeloma patients: a single center experience

BACKGROUND: Multiple myeloma (MM) constitutes approximately 10% of hematological malignancies. Bisphosphonates have established themselves in solid organ metastasis and multiple myeloma lytic bone lesions by inhibiting osteoclast activation. Medication-related osteonecrosis of the jaw (MRONJ) emerge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taş Ozyurtseven, Betul, Serin, Istemi, Nursal, Ayse Feyda, Pehlivan, Sacide, Pehlivan, Mustafa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130567/ https://www.ncbi.nlm.nih.gov/pubmed/34006261 http://dx.doi.org/10.1186/s12903-021-01634-9

Ejemplares similares

What are the roles of global DNA and APC 2 gene promotor hypermethylation in multiple myeloma?
por: Pehlivan, Sacide, et al.
Publicado: (2021)

The miRNA 196a2 rs11614913 variant has prognostic impact on Turkish patients with multiple myeloma
por: Kirik, Melya Pelin, et al.
Publicado: (2020)

A new parameter in multiple myeloma: CYP3A4*1B single nucleotide polymorphism
por: Serin, Istemi, et al.
Publicado: (2020)

Epigenetic and genetic investigation of SOCS-1 gene in patients with multiple myeloma
por: Tuncel, Fatıma Ceren, et al.
Publicado: (2022)

Association of the TNF-α, IL-2, and IL-2RB gene variants with susceptibility to psoriasis in a Turkish cohort
por: Gulel, Aslihan, et al.
Publicado: (2018)

PB2075: HOW EFFECTIVE ARE LEPTIN GENE POLYMORPHISMS AND METHYLATION DURING THE COURSE OF MULTIPLE MYELOMA (MM)?
por: Serin, Istemi, et al.
Publicado: (2023)

DNA Repair Genes and Chronic Myeloid Leukemia: ERCC2 (751), XRCC1 (399), XRCC4-Intron 3, XRCC4 (-1394) Gene Polymorphisms
por: Ozdilli, Kursat, et al.
Publicado: (2021)

Association of intron 4 VNTR polymorphism in the NOS3 gene with rapid cycling and treatment resistance in bipolar disorder: a case-control study
por: Aytac, Hasan M., et al.
Publicado: (2022)

Investigation of MBL2 and NOS3 functional gene variants in suspected COVID-19 PCR (–) patients
por: Pehlivan, Sacide, et al.
Publicado: (2021)

Imaging in Patients with Bisphosphonate-Associated Osteonecrosis of the Jaws (MRONJ)
por: Berg, Britt-Isabelle, et al.
Publicado: (2016)

Role of Teriparatide in Medication-Related Osteonecrosis of the Jaws (MRONJ)
por: Kwon, Yong-Dae, et al.
Publicado: (2016)

Effect of the uncoupling protein-2 (UCP-2) and nuclear receptor subfamily 3 group C member 1 (NR3C1) genes on treatment efficacy and survival in patients with multiple myeloma: a single-center study
por: Demir, Ilknur, et al.
Publicado: (2021)

Nutritional Status in Patients with Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Laimer, Johannes, et al.
Publicado: (2021)

Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Otto, Sven, et al.
Publicado: (2021)

Association between Hyperglycemia and Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Kammerhofer, Gabor, et al.
Publicado: (2023)

Dental practitioners' and students' knowledge of medication related osteonecrosis of the jaw (MRONJ)
por: Almousa, Mandlin Abdulaziz, et al.
Publicado: (2021)

Oral Complications in Cancer Patients–Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Migliorati, Cesar Augusto
Publicado: (2022)

Establishment and assessment of rodent models of medication-related osteonecrosis of the jaw (MRONJ)
por: Yan, Ran, et al.
Publicado: (2022)

Pathological fracture of the coronoid process secondary to medication-related osteonecrosis of the jaw (MRONJ)
por: Jowett, Adam, et al.
Publicado: (2015)

Medication-Related Osteonecrosis of the Jaw (MRONJ) due to Simvastatin: An Unusual Case Report
por: Samieirad, Sahand, et al.
Publicado: (2021)

Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020
por: Campisi, Giuseppina, et al.
Publicado: (2020)

Complementarity of Photo-Biomodulation, Surgical Treatment, and Antibiotherapy for Medication-Related Osteonecrosis of the Jaws (MRONJ)
por: Nica, Diana Florina, et al.
Publicado: (2021)

Conservative Management of Medication-Related Osteonecrosis of the Jaws (MRONJ): A Retrospective Cohort Study
por: Varoni, Elena M., et al.
Publicado: (2021)

The Role of Platelet-Rich Fibrin (PRF) in the Prevention of Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Miranda, Michele, et al.
Publicado: (2021)

Macrophage Involvement in Medication-Related Osteonecrosis of the Jaw (MRONJ): A Comprehensive, Short Review
por: Gkouveris, Ioannis, et al.
Publicado: (2022)

Medication-Related Osteonecrosis of the Jaws (MRONJ) in Children and Young Patients—A Systematic Review
por: Rosales, Hemil Dario, et al.
Publicado: (2023)

Imaging modalities for drug-related osteonecrosis of the jaw (2), Overview of the position paper on medication-related osteonecrosis of the jaw and the current status of the MRONJ in Japan
por: Shibahara, Takahiko
Publicado: (2019)

PB1967: ROLE OF CYTOKINES IN MULTIPLE MYELOMA: IL-1RN AND IL-4 VNTR POLYMORPHISMS
por: Serin, I., et al.
Publicado: (2022)

Surgical strategy for medication-related osteonecrosis of the jaw (MRONJ) on maxilla: A multicenter retrospective study
por: Okuyama, Kohei, et al.
Publicado: (2021)

Reporting Criteria for Clinical Trials on Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review and Recommendations
por: Gaudet, Camille, et al.
Publicado: (2022)

Radiographic Evaluation of Medication-Related Osteonecrosis of the Jaw (MRONJ) With Different Primary Cancers and Medication Therapies
por: Muttanahally, Kavya Shankar, et al.
Publicado: (2023)

COMTVal158Met polymorphism is associated with ecstasy (MDMA)-induced psychotic symptoms in the Turkish population
por: Aytac, Hasan Mervan, et al.
Publicado: (2022)

A New Clock is Running for Multiple Myeloma: Circadian Clock Protein-Period 3 (PER-3) Polymorphism
por: Serin, I., et al.
Publicado: (2023)

Investigation of inflammation related gene polymorphism of the mannose-binding lectin 2 in schizophrenia and bipolar disorder
por: Aytac, Hasan M., et al.
Publicado: (2021)

Perceptions and attitudes of patients towards medication-related osteonecrosis of the jaw (MRONJ): a qualitative study in England
por: Sturrock, Andrew, et al.
Publicado: (2019)

New Perspective for Soft Tissue Closure in Medication-Related Osteonecrosis of the Jaw (MRONJ) Using Barbed Sutures
por: Laimer, Johannes, et al.
Publicado: (2021)

A multicenter observational study on Medication-Related Osteonecrosis of the Jaw (MRONJ) in advanced cancer and myeloma patients of a cancer network in North-Western Italy
por: Fusco, Vittorio, et al.
Publicado: (2021)

The role of Leucocyte-rich and platelet-rich fibrin (L-PRF) in the treatment of the medication-related osteonecrosis of the jaws (MRONJ)
por: Cano-Durán, Jorge A., et al.
Publicado: (2017)

Awareness among patient at risk of developing Medication Related Osteonecrosis of the Jaw (MRONJ) – A primary prevention strategy
por: Al Abdullateef, Abdulrhman, et al.
Publicado: (2020)

Necrotizing periodontitis or medication-related osteonecrosis of the jaw (MRONJ) in a patient receiving Bemcentinib—a case report
por: Bumm, Caspar V., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cj2c20hr2q02efjpsgs2vukv7j